Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sage/Biogen Depression Data Likely To Prolong Commercial Debate
Feb 16 2022
•
By
Alaric DeArment
Sage/Biogen announced results from the Phase III CORAL study of zuranolone in major depressive disorder • Source: Shutterstock
More from Neurological
More from Therapeutic Category